Thrombocytopaenia Clinical Trial
Official title:
Indirect Comparison of Efficacy of Treatments for Idiopathic Immune Thrombocytopenic Purpura - Review of Platelet Responses and Bleeding Events
An indirect comparison to compare the efficacy of eltrombopag versus romiplostim
An indirect analysis was conducted to evaluate the relative efficacy of eltrombopag and romiplostim using placebo as a common comparator ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01440374 -
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
|
Phase 2 | |
Completed |
NCT01957176 -
A Rollover Study to Provide Continued Treatment With Eltrombopag
|
Phase 4 | |
Withdrawn |
NCT01055600 -
Milk-only Lactation Study for Patients on Eltrombopag
|
Phase 4 | |
Completed |
NCT01147809 -
Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
|
Phase 2 | |
Terminated |
NCT02158936 -
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
|
Phase 3 | |
Completed |
NCT00358540 -
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
|
Phase 1 | |
Completed |
NCT00102726 -
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
|
Phase 2 | |
Completed |
NCT01235988 -
Meta-analysis - Eltrombopag
|
N/A | |
Completed |
NCT01657552 -
Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects
|
Phase 1 |